KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation

SJ Chadban, C Ahn, DA Axelrod, BJ Foster… - …, 2020 - journals.lww.com
Abstract The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is …

Phosphate transport in epithelial and nonepithelial tissue

N Hernando, K Gagnon, E Lederer - Physiological reviews, 2021 - journals.physiology.org
Phosphate is an essential nutrient for life and is a critical component of bone formation, a
major signaling molecule, and structural component of cell walls. Phosphate is also a …

[HTML][HTML] Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney …

JV Torregrosa, J Bover, MR Portillo, EG Parra… - Nefrología (English …, 2023 - Elsevier
As in 2011, when the Spanish Society of Nephrology (SEN) published the Spanish
adaptation to the Kidney Disease: Improving Global Outcomes (KDIGO) universal Guideline …

Bone mineral disease after kidney transplantation

JV Torregrosa, AC Ferreira, D Cucchiari… - Calcified Tissue …, 2021 - Springer
Chronic kidney disease-mineral bone disorder (CKD-MBD) after kidney transplantation is a
mix of pre-existing disorders and new alterations. The final consequences are reflected …

Management of post-transplant hyperparathyroidism and bone disease

R Delos Santos, A Rossi, D Coyne, TT Maw - Drugs, 2019 - Springer
Significant advances in immunosuppressive therapies have been made in renal
transplantation, leading to increased allograft and patient survival. Despite improvement in …

A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation

IDB Marques, MJCLN Araújo, FG Graciolli… - Journal of the …, 2019 - journals.lww.com
Background Bone and mineral disorders commonly affect kidney transplant (KTx) recipients
and have been associated with a high risk of fracture. Bisphosphonates may prevent or treat …

Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy

MJCLN Araujo, JAM Ramalho, RM Elias, V Jorgetti… - Surgery, 2018 - Elsevier
Background Although a successful kidney transplant (KTx) improves most of the mineral and
bone disorders (MBD) produced by chronic kidney disease (CKD), hyperparathyroidism may …

[HTML][HTML] Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con …

JV Torregrosa, J Bover, MR Portillo, EG Parra… - nefrologia, 2022 - Elsevier
Al igual a como ocurrió en el año 2011, cuando la Sociedad Española de Nefrología (SEN)
publicó la adaptación española a las guías universales Kidney Disease Initiative Global …

Risk factors and management of osteoporosis post-transplant

K Kovvuru, SR Kanduri, P Vaitla, R Marathi, S Gosi… - Medicina, 2020 - mdpi.com
Bone and mineral disorders are common after organ transplantation. Osteoporosis post
transplantation is associated with increased morbidity and mortality. Pathogenesis of bone …

Exercise training in patients after kidney transplantation

S De Smet, AH Van Craenenbroeck - Clinical Kidney Journal, 2021 - academic.oup.com
Kidney transplantation is the treatment of choice for patients with end-stage renal disease.
Next to the risk of allograft failure, major obstacles for disease-free survival after kidney …